Outcomes Remain Poor in Blast-Phase CML, Despite Modern TKIs

(MedPage Today) — At the recent American Society of Hematology annual meeting, researchers presented real-world outcomes for patients with blast-phase chronic myeloid leukemia (CML) using data from a multi-institution U.S. cohort.
In this MedPage…

Source link : https://www.medpagetoday.com/meetingcoverage/ashvideopearls/119013

Author :

Publish date : 2025-12-15 17:55:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Outcomes Remain Poor in Blast-Phase CML, Despite Modern TKIs

Awareness of BRCA Status Drives Aggressive Surgery in Early-Onset Breast Cancer

FDA Approves Niraparib-abiraterone Acetate Combo for CSPC

Related Posts

Six Midlife Depressive Symptoms Tied to Dementia

Not Everyone Gets a Mortality Benefit From Reducing Saturated Fats, Study Says

FDA Approves Sexual Desire Drug for Postmenopausal Women

Aspiring Neurosurgeon Died in Brown Campus Shooting

Smartphone-Delivered Digital Therapy Improved Anxiety Symptoms

Lung Cancer Screening Follow-Up Often Inadequate

Six Midlife Depressive Symptoms Tied to Dementia

Not Everyone Gets a Mortality Benefit From Reducing Saturated Fats, Study Says

FDA Approves Sexual Desire Drug for Postmenopausal Women

Aspiring Neurosurgeon Died in Brown Campus Shooting

Smartphone-Delivered Digital Therapy Improved Anxiety Symptoms

Lung Cancer Screening Follow-Up Often Inadequate

Blockbuster Drug Lands First-Line Indication for HER2-Positive Breast Cancer

Second Oral Antibiotic for Gonorrhea Gets FDA Green Light

Categories

Archives